Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
出版年份 2022 全文链接
标题
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
作者
关键词
-
出版物
Hepatology International
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-30
DOI
10.1007/s12072-022-10431-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Primary biliary cholangitis
- (2021) Nora Cazzagon et al. CURRENT OPINION IN GASTROENTEROLOGY
- A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
- (2021) Jörn M. Schattenberg et al. JOURNAL OF HEPATOLOGY
- Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
- (2021) Anna Reig et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel
- (2020) Domenico Alvaro et al. LIVER INTERNATIONAL
- Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis
- (2019) Akira Honda et al. HEPATOLOGY
- The challenges of primary biliary cholangitis: What is new and what needs to be done
- (2019) Benedetta Terziroli Beretta-Piccoli et al. JOURNAL OF AUTOIMMUNITY
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- Current and potential treatments for primary biliary cholangitis
- (2019) Raj A Shah et al. Lancet Gastroenterology & Hepatology
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Management of Primary Biliary Cholangitis
- (2018) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Predicting risk in primary biliary cholangitis
- (2016) Bertus Eksteen HEPATOLOGY
- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
- (2014) Willem J. Lammers et al. GASTROENTEROLOGY
- Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study
- (2013) Li-Na Zhang et al. HEPATOLOGY
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis
- (2011) Njideka Momah et al. LIVER INTERNATIONAL
- Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
- (2010) Teru Kumagi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis
- (2009) Nobuaki Azemoto et al. JOURNAL OF GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More